journal article·2016-10-12

Design of a Redox-Sensitive Supramolecular Protein Assembly System Operating in Live Cells

Giuliano Bellapadrona, Michael Elbaum

Nano Letters· Volume 16· Issue 10
Publisher page

Abstract

A fusion construct between Citrine (a YFP variant) and human ferritin (H-chain) was recently shown to form supramolecular assemblies of micrometer size when expressed in mammalian cells. The assembly process is driven by weak hydrophobic interactions leading to dimerization of YFP. Protein assembly could be suppressed at the gene level by mutation in the primary sequence of the construct. In this work, we describe the engineering of a self-assembly interface sensitive to redox state in the cell. Key hydrophobic residues of YFP were mutated systematically to cysteines. Supramolecular assembly of the Citrine-ferritin construct was in some cases preserved by formation of disulfide bonds in place of hydrophobic interactions. In others cases, assembly was abolished, resulting in a diffuse distribution of the expressed protein. A specific variant that remained diffuse under normally reducing intracellular conditions was found to self-assemble rapidly upon exposure to a thiol-specific oxidizing reagent.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Protein Structure and Dynamics · Amino Acid Enzymes and Metabolism · Supramolecular Self-Assembly in Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Materials and Interfaces, Weizmann Institute of Science, Rehovot 76100, Israel

Funding

Israel Science Foundation · Gerhardt M.J. Schmidt Minerva Center on Supramolecular Architecture, Weizmann Institute of Science

References (22)

Show source-provided references
1. Henriksen A. · EMBO J. · 2001 · 20 · 585310.1093/emboj/20.21.5853 ↗
2. 10.1016/j.bbagen.2013.05.03010.1016/j.bbagen.2013.05.030 ↗
3. 10.1002/biot.20130019910.1002/biot.201300199 ↗
4. 10.1016/j.yjmcc.2013.12.02310.1016/j.yjmcc.2013.12.023 ↗
5. 10.1016/j.bbrc.2014.12.09510.1016/j.bbrc.2014.12.095 ↗
6. 10.1177/108705711349963410.1177/1087057113499634 ↗
7. 10.1016/j.freeradbiomed.2013.07.03310.1016/j.freeradbiomed.2013.07.033 ↗
8. 10.1074/jbc.M31284620010.1074/jbc.M312846200 ↗
9. 10.1016/j.bbabio.2014.01.02010.1016/j.bbabio.2014.01.020 ↗
10. 10.1371/journal.pone.009836210.1371/journal.pone.0098362 ↗
11. 10.1038/ncomms962410.1038/ncomms9624 ↗
12. 10.1016/S0009-8981(03)00200-610.1016/S0009-8981(03)00200-6 ↗
13. 10.1016/j.bbagen.2014.11.01010.1016/j.bbagen.2014.11.010 ↗
14. 10.1080/1521654070119694410.1080/15216540701196944 ↗
15. 10.1002/anie.20130916310.1002/anie.201309163 ↗
16. 10.1038/nchembio.116310.1038/nchembio.1163 ↗
17. 10.1002/anie.20110146710.1002/anie.201101467 ↗
18. 10.1038/nbt1096-124610.1038/nbt1096-1246 ↗
19. 10.1074/jbc.M10281520010.1074/jbc.M102815200 ↗
20. 10.1002/jcc.2008410.1002/jcc.20084 ↗
21. 10.1016/j.bbamcr.2007.10.01310.1016/j.bbamcr.2007.10.013 ↗
22. 10.1021/acs.biomac.5b0043510.1021/acs.biomac.5b00435 ↗